The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Stephen Worthley
Showing 1-18 of 18 articles
Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study
Sondergaard L,
Walton A,
Worthley S,
Smith D,
Chehab B,
Manoharan G,
Yong G,
Bedogni F,
Bates N,
Reardon M
June 19, 2023 | 10.4244/EIJ-D-22-01108
Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial
Worthley S,
Redwood S,
Hildick-Smith D,
Rafter T,
Whelan A,
De Marco F,
Horrigan M,
Delacroix S,
Gregson J,
Erglis A
January 20, 2021 | 10.4244/EIJ-D-20-00484
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R,
Worthley S,
Whitbourn R,
Montarello J,
Newcomb A,
Allocco DJ,
Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study
Maisano F,
Worthley S,
Rodés-Cabau J,
Linke A,
Fichtlscherer S,
Schäfer U,
Makkar R,
Fontana G,
Asch FM,
Søndergaard L
October 19, 2018 | 10.4244/EIJ-D-18-00343
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve
Kim U,
Blanke P,
Windecker S,
Kasel AM,
Schäfer U,
Walters D,
Linke A,
Le Breton H,
Schymik G,
Spence M,
Søndergaard L,
Abdel-Wahab M,
Worthley S,
Tchétché D,
Reichenspurner H,
Ohana M,
Sellers SL,
Leipsic J
August 3, 2018 | 10.4244/EIJ-D-17-01040
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchétché D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem NM,
Feldman T,
Allocco DJ,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N,
Meredith I,
Blackman D,
Tchétché D,
Hildick-Smith D,
Spence M,
Walters D,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem NM,
Houle V,
Allocco DJ,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Aortic atheroma burden predicts acute cerebrovascular events after transcatheter aortic valve implantation: insights from volumetric multislice computed tomography analysis
Kataoka Y,
Puri R,
Pisaniello A,
Hammadah M,
Qintar M,
Uno K,
Montarello J,
Nicholls S,
Worthley S
August 20, 2016 | 10.4244/EIJV12I6A127
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach
Tzikas A,
Gafoor S,
Meerkin D,
Freixa X,
Cruz-González I,
Lewalter T,
Saw J,
Berti S,
Nielsen-Kudsk J,
Ibrahim R,
Lakkireddy D,
Paul V,
Arzamendi D,
Nietlispach F,
Worthley S,
Hildick-Smith D,
Thambo J-B,
Tondo C,
Aminian A,
Kalarus Z,
Schmidt B,
Søndergaard L,
Kefer J,
Meier B,
Park J,
Sievert H,
Omran H
April 20, 2016 | 10.4244/EIJV11I13A292
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease
Puri R,
Leong D,
Nicholls S,
Liew G,
Nelson A,
Carbone A,
Copus B,
Wong D,
Beltrame J,
Worthley S,
Worthley M
April 20, 2015 | 10.4244/EIJV10I12A249
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K,
Koo B,
Waseda K,
Nakatani D,
Yock P,
Whitbourn R,
Worthley S,
Ormiston J,
Webster M,
Wilkins G,
Honda Y,
Meredith I,
Fitzgerald P
March 20, 2015 | 10.4244/EIJY14M08_16
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I,
Worthley S,
Whitbourn R,
Antonis P,
Montarello J,
Newcomb A,
Lockwood S,
Haratani N,
Allocco DJ,
Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I,
Dubois C,
Dens J,
Ormiston J,
Worthley S,
McClean D,
Ottervanger J,
Meredith I,
Uren N,
Wijns W,
Whitbourn R,
Mehran R,
Lansky AJ,
Bichalska M,
Meis S,
Verheye S
September 27, 2013 | 10.4244/EIJV9I5A93
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning A,
Abizaid A,
Bartorelli AL,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong MH,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley S,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
First-in-human experience with the Medtronic Bifurcation Stent System
Meredith I,
Worthley S,
Whitbourn R,
Webster M,
Fitzgerald P,
Ormiston J
October 28, 2011 | 10.4244/EIJV7I6A108
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial
Meredith I,
Worthley S,
Whitbourn R,
Walters D,
McClean D,
Ormiston J,
Horrigan M,
Wilkins G,
Hendriks R,
Matsis P,
Muller DW,
Cutlip D
January 15, 2010
The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial
Meredith I,
Worthley S,
Whitbourn R,
Walters D,
Popma J,
Cutlip D,
Fitzgerald P
May 22, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial
Chevalier B,
Serruys P,
Silber S,
Garcia E,
Suryapranata H,
Hauptmann K-E,
Wijns W,
Schuler G,
Fath-Ordoubadi F,
Worthley S,
Thuesen L,
Meredith I,
Bressers M,
Nagai H,
Paunovic D
February 20, 2007
1
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023